# Executive Summary - Diabetes Prediction Project

## Business Objective
A healthcare organization aims to identify patients at risk of diabetes early to support 
preventive care strategies and early intervention.

## Key Diabetes Insights

### Prevalence
- **Overall diabetes prevalence**: 8.5% of patients in the dataset have diabetes
- **Total patients analyzed**: 100,000
- **Diabetic patients**: 8,500

### High-Risk Segments
Based on our analysis, the following patient segments show significantly higher diabetes rates:

1. **Age**: Patients aged 65+ have the highest diabetes rates
2. **BMI**: Obese patients (BMI > 30) show elevated diabetes risk
3. **Comorbidities**: Patients with hypertension and/or heart disease have approximately 2x higher diabetes rates
4. **Clinical Measurements**: Higher HbA1c and blood glucose levels are strongly associated with diabetes

## Model Performance Summary

| Metric | Value |
|--------|-------|
| Model | LightGBM |
| Test ROC-AUC | 0.9784 |
| Test Precision | 0.9459 |
| Test Recall | 0.6988 |
| Test F1 Score | 0.8038 |

The model achieves strong predictive performance with:
- **97.8%** ROC-AUC (exceeds 80% target)
- **69.9%** recall for diabetic patients (exceeds 60% target)

## High-Risk Patients

- **High-risk patients identified**: 1478 (probability >= 70%)
- **Actual diabetic in high-risk group**: 1036 (70.1% accuracy)
- **Recommended action**: Prioritize these patients for clinical follow-up and preventive interventions

## Assumptions and Limitations

1. **Correlation ≠ Causation**: Our analysis identifies associations, not causal relationships
2. **Data Leakage Note**: HbA1c_level and blood_glucose_level are clinical measurements directly related to diabetes diagnosis
3. **Population Specificity**: Results are based on this specific dataset and may not generalize to all populations
4. **Model Use**: Predictions should support, not replace, clinical judgment

## Recommended Next Actions

1. **Implement screening program** using the model to identify high-risk patients
2. **Target interventions** at high-risk segments (elderly, obese, patients with comorbidities)
3. **Monitor model performance** in production and retrain periodically
4. **Conduct clinical validation** before full-scale deployment
5. **Explore additional features** that may improve prediction accuracy

---

*Report generated from Diabetes Prediction Project*
*Date: 2026*
